Drug helps patients with diabetes lose weight

Among overweight and obese patients with type 2 diabetes, daily injection of the diabetes drug liraglutide with a modified insulin pen device, in addition to diet and exercise, resulted in greater weight loss over 56 weeks ...


Nature of beta-cell failure tied to glycemic response to GLP-1RA

(HealthDay)—In patients with type 2 diabetes, characteristics and biomarkers of β-cell failure are associated with glycemic response to GLP-1 receptor agonist (GLP-1RA) therapy, according to a study published online Aug. ...


Drinking at conception boosts diabetes risk for baby

Babies conceived by women who drink alcohol around the time of conception face dramatically increased risks of type 2 diabetes and obesity in early middle age, a University of Queensland study has found.


Low incidence of diabetic ketoacidosis with canagliflozin

(HealthDay)—For canagliflozin-treated patients with type 2 diabetes, the incidence of serious adverse events of diabetic ketoacidosis (DKA) is low, according to research published online July 22 in Diabetes Care.

page 3 from 40